Tekla Capital Management’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Tekla Capital Management’s Portfolio FUSN Stock Details FUSN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$203K	Hold	43,394	–	–	0.01%	153
2023 Q1	$164K	Hold	43,394	–	–	0.01%	169
2022 Q4	$137K	Sell	43,394 -58,537	-57%	-$146K	0.01%	165
2022 Q3	$605K	Buy	101,931 +58,537	+135%	+$146K	0.02%	143
2022 Q2	$108K	Hold	43,394	–	–	﹤0.01%	170
2022 Q1	$337K	Hold	43,394	–	–	0.01%	166
2021 Q4	$181K	Hold	43,394	–	–	0.01%	164
2021 Q3	$344K	Buy	+43,394	New	+$365K	0.01%	166

Other funds holding FUSN

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

APM

Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Johnson & Johnson New Brunswick, New Jersey $652M AUM 198.07% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

ASP

Adams Street Partners Chicago, Illinois $260M AUM 30.38% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

TGA

TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return

Tekla Capital Management's FUSN Position: Q2 2023 in Review

Tekla Capital Management held its Fusion Pharmaceuticals Inc. Common Shares (FUSN) position steady in Q2 2023 at 43,394 shares worth $203K. The position accounts for 0.01% of the portfolio, ranked #153.

Tekla Capital Management first reported a position in FUSN in Q3 2021 and has held it in 8 quarters since. The position peaked at $605K in Q3 2022. 41 funds tracked by Wall St. Rank hold FUSN as of Q2 2023.

Tekla Capital Management held 43,394 shares of Fusion Pharmaceuticals Inc. Common Shares worth $203K as of Q2 2023.
Tekla Capital Management left its Fusion Pharmaceuticals Inc. Common Shares share count unchanged in Q2 2023.
Fusion Pharmaceuticals Inc. Common Shares made up 0.01% of Tekla Capital Management's portfolio in Q2 2023, its #153 holding.
Tekla Capital Management first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q3 2021 and has held it in 8 quarters since.
Tekla Capital Management's Fusion Pharmaceuticals Inc. Common Shares position peaked at $605K in Q3 2022.
41 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.